Regeneron Japan KK is a subsidiary of Regeneron Pharmaceuticals, a leading biotechnology company dedicated to inventing life-transforming medicines for individuals with serious diseases. With over 30 years of experience, Regeneron is renowned for its unique ability to translate scientific discoveries into effective treatments, resulting in nine FDA-approved therapies and a robust pipeline of product candidates. The company focuses on various therapeutic areas, including oncology, eye diseases, allergic and inflammatory conditions, cardiovascular and metabolic disorders, neurology, infectious diseases, and rare diseases. Regeneron is committed to fostering a culture of innovation and has been recognized as a Great Place to Work and one of Fast Company's Best Workplaces for Innovators. The company values diversity and inclusion, offering comprehensive benefits to its employees while adhering to ethical standards in the pharmaceutical industry.